Markel Group (MKL) slides as Q1 investment losses overshadow solid underwriting

Markel Group (MKL) is down 7.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to Markel’s first-quarter 2026 results, where a large mark-to-market investment loss pushed reported results into the red despite improved underwriting performance. Investors often react more strongly to GAAP losses and book-value volatility for insurer-investors like Markel, particularly when equity-portfolio moves dominate the quarter’s headline figures.

Details:

Markel reported an operating loss of $273 million for Q1 2026, versus operating income in the prior-year quarter.

Net investment losses were $727.6 million in the quarter, which the company noted reflected market movements in its equity portfolio.

Comprehensive loss to shareholders was $340.4 million, driven primarily by unrealized losses on the investment portfolio.

Within Markel Insurance, the combined ratio improved to 93% and included roughly two points of net losses tied to the Middle East conflict; underwriting gross premium volume fell 21% largely due to portfolio changes (including the prior renewal-rights sale in Global Reinsurance and a Hagerty fronting transition).

Sources:

Markel Group Investor Relations, SEC (EDGAR)

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$MKL Insider Trading Activity

$MKL insiders have traded $MKL stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $MKL stock by insiders over the last 6 months:

STEVEN A MARKEL has made 0 purchases and 18 sales selling 1,500 shares for an estimated $3,175,429.
SIMON WILSON (EVP and CEO, Markel Insurance) has made 0 purchases and 2 sales selling 175 shares for an estimated $363,418.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$MKL Hedge Fund Activity

We have seen 360 institutional investors add shares of $MKL stock to their portfolio, and 365 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CANERECTOR INC removed 10,697,981 shares (-99.9%) from their portfolio in Q4 2025, for an estimated $22,996,914,856
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 276,814 shares (-78.1%) from their portfolio in Q4 2025, for an estimated $595,053,215
JANA PARTNERS MANAGEMENT, LP removed 66,192 shares (-44.9%) from their portfolio in Q4 2025, for an estimated $142,289,632
MORGAN STANLEY removed 56,263 shares (-12.5%) from their portfolio in Q4 2025, for an estimated $120,945,757
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 53,429 shares (-34.4%) from their portfolio in Q4 2025, for an estimated $114,853,649
SELECT EQUITY GROUP, L.P. added 45,150 shares (+11.8%) to their portfolio in Q4 2025, for an estimated $97,056,697
DAVIS SELECTED ADVISERS added 41,632 shares (+11.1%) to their portfolio in Q4 2025, for an estimated $89,494,228

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$MKL Congressional Stock Trading

Members of Congress have traded $MKL stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MKL stock by members of Congress over the last 6 months:

REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $50,000 on 01/23.
REPRESENTATIVE APRIL MCCLAIN DELANEY purchased up to $15,000 on 11/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.